drugset / Trial / NCT00662883
Assessing the Effects of a Nasal Corticosteroid on PMI-150 (Intranasal Ketamine)
NaSingle-groupOpen-label
Summary
To assess the effects of nasal corticosteroid treatment on the rate and extent of intranasal absorption of PMI-150 (intranasal ketamine HCl)
Timeline
- Start
- 2007-11
- Primary completion
- 2008-02
- Completion
- 2008-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 30 mg | Intranasal |
| Subject | Mometasone furoate | Other / unclassified | — | Intranasal |
Indications
No indication recorded.